The Cell Therapy Thematic Research Center at Bristol Myers Squibb develops innovative engineered cell-based therapies that harness the immune system to treat hematologic malignancies, solid cancers, and autoimmune disease. The Scientist, Non-Viral Gene Editing Platforms works primarily in the laboratory, independently conducting experiments and documenting results in an electronic lab notebook. The role contributes to optimizing ex vivo gene-editing platforms, implementing new technologies, and developing next-generation in vivo platforms such as lipid nanoparticles. The scientist generates and characterizes engineered CAR-T cells, analyzes and interprets experimental data, troubleshoots routine issues, communicates findings, and supports cross-functional and multidisciplinary team efforts. The position requires a bachelor's degree with at least five years of academic and/or industry experience, a master's degree with at least three years of experience, or a Ph.D. or equivalent advanced degree in the life sciences. Preferred qualifications include hands-on gene-editing and in vivo gene-delivery experience, molecular biology expertise, T-cell culture and flow cytometry experience, and strong organization, teamwork, communication, and documentation skills. The role is listed for Seattle, Washington, with a starting pay range of $122,810–$148,814. Eligible employees may receive discretionary cash and stock incentives and may participate in benefit plans, including insurance, retirement and financial protection benefits, and applicable paid time off and leave programs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level